BioSpace News Archive

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President and Chief Executive Officer, will provide a company overview at the H.C. Wainwright BioConnect 2021 Conference, held virtually from January 11-14, 2021. A copy of the presentation will be available on the “Investors” section of the Company’s website www.korumedical.com .

- Round co-led by Apeiron Investment Group and Catalio Capital Management - Proceeds support advancement of lead product candidate and next-generation platform for personalized yet off-the-shelf cancer immunotherapies

BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, welcomes Krisztina Zsebo, Ph.D., a 31-year veteran of the biotech industry, to its Board of Directors following her election at BioCardia’s 2020 Annual Meeting of Stockholders in December 2020. Dr. Zsebo has extensive biotechnology experience in discovery, development, and commercialization, having raised mo

Tamar Thompson and Jean Kim appointed to Board of Directors replacing Todd Brady and Michael Martin

Dyadic International, Inc. , today announced the appointment of Patrick Lucy, to its Board of Directors, effective January 8, 2021.

New COVID-19 strain estimated to have tripled number of infections in England during November 2020 lockdown Investor webcast scheduled for Thursday, January 14 at 11:30 A.M. Eastern Time.

AXIM ® Biotechnologies, Inc . (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it has released a preprint of its manuscript describing the development of ImmunoPass, the Company’s rapid point-of-care test that semi-quantitatively measures levels of neutralizing antibodies to COVID-19.

Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has entered into an agreement with Bitmedical AG (“Bitmedical”) to distribute the CompuFlo® Epidural Instrument and CathCheck™ System, as well as related disposables in Switzerland and Austria.

Noctrix Health, Inc., a private medical device company, today announced it has completed a Series B financing of $17 million . The financing was co-led by Treo Ventures and OrbiMed, with participation from LivaNova PLC (NASDAQ: LIVN) and other insiders.

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that it has expanded its existing French distribution partnership agreement with MicroPort CRM in France to include both Spain and Portugal.